Pharmaceuticals, Biotechnology and Life Sciences
Study recently published by Penn team in Cell Reports provides evidence that NLY01 has the potential for clinical use in…
BOSTON–(BUSINESS WIRE)–AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will present at…
DENVER–(BUSINESS WIRE)–MedPharm Holdings, a leading medical cannabis manufacturer, R&D laboratory, and compounding facility, won awards in two categories at the…
Dr. Aiyar brings nearly two decades of diverse experience across biotech and pharma to prepare for Korro’s next stage of…
– Program to Support Weekly Testing of Up to 9,000 Faculty and Staff at Peak Operations, Equates to Use of…
Trial also met the primary endpoint in patients with low levels of eosinophils WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and Amgen today announced…
Late Breaker to be Presented by Leading Ocular Oncologist, Carol L. Shields, M.D., Director, Ocular Oncology Service, Wills Eye Hospital…
LENVIMA Plus Everolimus Also Showed Statistically Significant Improvement in PFS and ORR Endpoints Versus Sunitinib Results of Investigational Phase 3…
SQZ presents five posters, including Phase 1 SQZ-PBMC-HPV-101 Trial-in-Progress poster WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies (NYSE: SQZ), a cell therapy company…
PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange, the leading SaaS-enabled marketplace platform for outsourced R&D services, has partnered with the European Quality…